About Congenital myasthenic syndrome due to defective synthesis or recycling of acetylcholine
Congenital myasthenic syndrome due to defective synthesis or recycling of acetylcholine is a rare disease catalogued by Orphanet (ORPHA:716893). Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries worldwide.
Clinical Trial Eligibility Tips
What to know before applying to Congenital myasthenic syndrome due to defective synthesis or recycling of acetylcholine trials.
Search ClinicalTrials.gov for "Congenital myasthenic syndrome due to defective synthesis or recycling of acetylcholine" or Orphanet code ORPHA:716893 to find disease-specific recruiting studies.
Ask your specialist to refer you to an Orphanet-accredited Centre of Expertise for this condition.
Natural history studies and patient registries often open enrolment before drug trials — contact the Orphanet patient community first.
Patient Resources
Find recruiting Congenital myasthenic syndrome due to defective synthesis or recycling of acetylcholine trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Congenital myasthenic syndrome due to defective synthesis or recycling of acetylcholine. Updated daily.